Angela Lamarca, Medical Oncologist at Jiménez Díaz Foundation, shared on X:
“Dr. Castven awarded with Gold Award by ENS-CCA (European Network for the Study of Cholangiocarcinoma), Precision-BTC-Network for his work on ‘Specific inhibition of PARP1 preferentially impairs KRAS mutated iCCA’.
Great example of translations into the clinic to find new treatment options.”
Source: Angela Lamarca/X
